451 related articles for article (PubMed ID: 30927912)
1. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
[TBL] [Abstract][Full Text] [Related]
2. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
[TBL] [Abstract][Full Text] [Related]
4. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone suppresses TGF‑β1‑induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway.
Sun Y; Zhang Y; Chi P
Mol Med Rep; 2018 Oct; 18(4):3907-3913. PubMed ID: 30152848
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
[TBL] [Abstract][Full Text] [Related]
8. Concurrent inhibition of TGF-β and mitogen driven signaling cascades in Dupuytren's disease - non-surgical treatment strategies from a signaling point of view.
Krause C; Kloen P
Med Hypotheses; 2012 Mar; 78(3):385-8. PubMed ID: 22196988
[TBL] [Abstract][Full Text] [Related]
9. PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling.
Thomas PE; Peters-Golden M; White ES; Thannickal VJ; Moore BB
Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L417-28. PubMed ID: 17557799
[TBL] [Abstract][Full Text] [Related]
10. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
[TBL] [Abstract][Full Text] [Related]
11. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.
Oezel L; Wohltmann M; Gondorf N; Wille J; Güven I; Windolf J; Thelen S; Jaekel C; Grotheer V
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894778
[TBL] [Abstract][Full Text] [Related]
12. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.
Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S
Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824
[TBL] [Abstract][Full Text] [Related]
14. Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.
Li X; Zhang ZL; Wang HF
Biomed Pharmacother; 2017 Sep; 93():130-145. PubMed ID: 28624424
[TBL] [Abstract][Full Text] [Related]
15. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-β1/Smad/CTGF signaling pathway.
Sun YW; Zhang YY; Ke XJ; Wu XJ; Chen ZF; Chi P
Eur J Pharmacol; 2018 Mar; 822():199-206. PubMed ID: 29374548
[TBL] [Abstract][Full Text] [Related]
16. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
Wong M; Mudera V
J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
[TBL] [Abstract][Full Text] [Related]
17. Verteporfin ameliorates fibrotic aspects of Dupuytren's disease nodular fibroblasts irrespective the activation state of the cells.
Puerta Cavanzo N; Riesmeijer SA; Holt-Kedde IL; Werker PMN; Piersma B; Olinga P; Bank RA
Sci Rep; 2022 Aug; 12(1):13940. PubMed ID: 35977978
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts.
Shyu KG; Wang BW; Chen WJ; Kuan P; Hung CR
Eur J Heart Fail; 2010 Mar; 12(3):219-26. PubMed ID: 20156938
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 increases basal and TGF-beta1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts.
Kim S; Lee Y; Seo JE; Cho KH; Chung JH
Cell Signal; 2008 Jul; 20(7):1313-9. PubMed ID: 18434090
[TBL] [Abstract][Full Text] [Related]
20. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
